SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-003470
Filing Date
2020-02-13
Accepted
2020-02-13 08:03:49
Documents
52
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q1219_delmarpharma.htm 10-Q 1147633
2 CERTIFICATION f10q1219ex31-1_delmarpharma.htm EX-31.1 13801
3 CERTIFICATION f10q1219ex31-2_delmarpharma.htm EX-31.2 13968
4 CERTIFICATION f10q1219ex32-1_delmarpharma.htm EX-32.1 5079
5 CERTIFICATION f10q1219ex32-2_delmarpharma.htm EX-32.2 5086
6 GRAPHIC img_001.jpg GRAPHIC 13817
  Complete submission text file 0001213900-20-003470.txt   4184547

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE dmpi-20191231.xml EX-101.INS 778316
8 XBRL SCHEMA FILE dmpi-20191231.xsd EX-101.SCH 47324
9 XBRL CALCULATION FILE dmpi-20191231_cal.xml EX-101.CAL 32989
10 XBRL DEFINITION FILE dmpi-20191231_def.xml EX-101.DEF 158652
11 XBRL LABEL FILE dmpi-20191231_lab.xml EX-101.LAB 295796
12 XBRL PRESENTATION FILE dmpi-20191231_pre.xml EX-101.PRE 224488
Mailing Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130
Business Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130 (858) 350-4364
DelMar Pharmaceuticals, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-37823 | Film No.: 20607044
SIC: 2834 Pharmaceutical Preparations